FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098866 [Registered on: 11/12/2025] Trial Registered Prospectively
Last Modified On: 10/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Clinical study to evaluate the efficacy of Shatavari Kwatha along with its Antimicrobial effect in Garbhini Mutrakrichhra w.s.r. to UTI in Pregnancy 
Scientific Title of Study   A Clinical study to evaluate the efficacy of Shatavari Kwatha along with its Antimicrobial effect in Garbhini Mutrakrichhra w.s.r. to UTI in Pregnancy 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr.Seema Shukla  
Designation  Retired Professor 
Affiliation  Rajiv Gandhi Government Post Graduate Ayurvedic College and hospital PaprolaDistt kangra HP 176115  
Address  Re-employed At Awasthi Ayurvedic Medical College And Hospital Nalagarh Dist .Solan 174101

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418008833  
Fax    
Email  drseemanil@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Soni Kapil 
Designation  HOD Professor, Prasuti Tantra evum Stree Roga 
Affiliation  Rajiv Gandhi Government Post Graduate Ayurvedic College and hospital PaprolaDistt kangra HP 176115  
Address  P.G. dept of PTSR, Room No 203,Rajiv Gandhi Government Post Graduate Ayurvedic College and hospital Paprola Distt kangra Baijnath Himachal Pradesh 176115 India

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418499799  
Fax    
Email  skbhardwaj73@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nikita Nagre  
Designation  PG Scholar, Prasuti Tantra evum Stree Roga 
Affiliation  Rajiv Gandhi Government Post Graduate Ayurvedic College and hospital Paprola Distt kangra HP  
Address  Rajiv Gandhi Government Post Graduate Ayurvedic College and hospital Paprola Distt kangra Baijnath HP 176115 India

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9604283070  
Fax    
Email  nikitanagre0309@gmail.com  
 
Source of Monetary or Material Support  
HP Charak pharmacy, Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital Paprola Distt Kangra, HP, 176115 Research Institute in ISM Jogindernagar, Distt Mandi HP  
 
Primary Sponsor  
Name  Government of Himachal Pradesh 
Address  HP Secretariat Shimla, 171002, H.p. india 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSeema Shukla  Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital Paprola Distt Kangra HP   OPD and IPD Department of Prasuti Tantra evum Stree Roga,RGGPG Ayurvedic College and Hospital Paprola Distt Kangra HP Kangra HIMACHAL PRADESH
Kangra
HIMACHAL PRADESH 
9418008833

drseemanil@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee ( Human) Rajiv Gandhi Government Postgraduate Ayurvedic College and Hospital Paprola District Kangra Himachal Pradesh  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N390||Urinary tract infection, site notspecified. Ayurveda Condition: MUTRAKRUCCRAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Shatavari kwath, Reference: yogratnakar, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 24(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 10 Days, anupAna/sahapAna: Yes(details: -madhu), Additional Information: -
2Comparator Arm (Non Ayurveda)-NitrofurantoinNitrofuranton 100 mg 12 hourly for 7 days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  i. Pregnant female patients. (13 to 38 weeks of GA).
ii. Clinically diagnosed patients which fell under symptomatic criteria of Garbhini
Mutrakrichhra
 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
overall assessment will be seen in improvement in
subjective or objective criteria and also in
conception  
10 days 
 
Secondary Outcome  
Outcome  TimePoints 
overall assessment will be seen in improvement in
subjective or objective criteria and also in
conception  
Twice in day for 10days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   21/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  21/12/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Research report will be soon published after the completion of trial 60 patients fulfilling the inclusion and exclusion criterias will be randomly selected from the OPD and IPD of department of Prasuti Tantra evum Stri Roga , RGGPG Ayurvedic College and Hospital Paprola Distt Kangra HP. Patients will be divided into 2 groups of 30 each .1. Patient will be managed with shatavari kawath 48 ml bd for 10 days . Drug free follow up will be 15 days  of completion of trial Result will be assessed on the basis of subjective and objective criterias 
Close